413 related articles for article (PubMed ID: 12928694)
1. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
2. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
3. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.
Weger M; Renner W; Steinbrugger I; Cichocki L; Temmel W; Stanger O; El-Shabrawi Y; Lechner H; Schmut O; Haas A
Ophthalmology; 2005 Nov; 112(11):1910-5. PubMed ID: 16157382
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of C807T mutation of glycoprotein Ia gene among young male survivors of myocardial infarction: a relation with coronary angiography results.
Lewandowski K; Swierczyńska A; Kwaśnikowski P; Elikowski W; Rzeźniczak M
Kardiol Pol; 2005 Aug; 63(2):107-13; discussion114. PubMed ID: 16136407
[TBL] [Abstract][Full Text] [Related]
5. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.
Amitrano L; Brancaccio V; Guardascione MA; Margaglione M; Iannaccone L; D'Andrea G; Marmo R; Ames PR; Balzano A
Hepatology; 2000 Feb; 31(2):345-8. PubMed ID: 10655256
[TBL] [Abstract][Full Text] [Related]
6. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
Eroglu A; Egin Y; Cam R; Akar N
Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
10. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
11. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
12. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation.
Loewenstein A; Goldstein M; Winder A; Lazar M; Eldor A
Ophthalmology; 1999 Sep; 106(9):1817-20. PubMed ID: 10485556
[TBL] [Abstract][Full Text] [Related]
13. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
[TBL] [Abstract][Full Text] [Related]
14. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
16. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause.
Brenner B; Sarig G; Weiner Z; Younis J; Blumenfeld Z; Lanir N
Thromb Haemost; 1999 Jul; 82(1):6-9. PubMed ID: 10456445
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5 (NOHA5).
Gris JC; Quéré I; Monpeyroux F; Mercier E; Ripart-Neveu S; Tailland ML; Hoffet M; Berlan J; Daurès JP; Marès P
Thromb Haemost; 1999 Jun; 81(6):891-9. PubMed ID: 10404763
[TBL] [Abstract][Full Text] [Related]
18. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
Russo PD; Damante G; Pasca S; Turello M; Barillari G
Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
[TBL] [Abstract][Full Text] [Related]
19. Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation.
Pereboom IT; Adelmeijer J; van der Steege G; van den Berg AP; Lisman T; Porte RJ
Transplantation; 2011 Sep; 92(5):587-93. PubMed ID: 21836539
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
